Development of a new antimicrobial drug based on quaternary ammonium compounds
نویسندگان
doi
10.48309/jmpcr.2026.530166.1739چکیده
This study presents the development of "Quatersan", a novel disinfectant based on quaternary ammonium compounds (QACs) with enhanced antimicrobial properties. Through systematic screening of 270 synthesized compounds, we identified 53 exhibiting antimicrobial activity, with 7 showing particularly high efficacy against clinically relevant pathogens. The lead compound demonstrated superior performance with minimum inhibitory concentrations (MIC) of 0.05 mg/mL against Staphylococcus aureus ATCC 6538, 0.07 mg/mL against Escherichia coli ATCC 25922, and 0.10 mg/mL against Candida albicans ATCC 10231 - representing a 2-4 fold improvement over standard chlorhexidine. Structure-activity analysis revealed that antimicrobial potency strongly correlates with halogen radical presence in 2-halopyridine-3-carbonitrile derivatives. Comprehensive evaluation including serial passage experiments confirmed no resistance development in test strains after 30 generations. Industrial trials demonstrated 98.5% disinfection efficacy across different surfaces (metal, plastic, and wood), with complete material compatibility and competitive cost-efficiency at $0.20/m². Toxicological assessment classified "Quatersan" as category III (moderately hazardous) per WHO guidelines, with no observed skin irritation or tissue damage. These findings position "Quatersan" as a promising next-generation disinfectant combining: broad-spectrum antimicrobial activity, resistance prevention, and practical advantages for clinical and veterinary applications.